Table 2 The anti-inflammatory activity of Mel-C/L nanoparticles.
Sample (µg/ml) | Absorbance (m ± SD) | Hemolysis inhibition % | ||
|---|---|---|---|---|
Hypotonic solution | Isotonic solution | |||
Control | 1.514 | 0.09 ± 0.01 | ||
Nanoparticles | 1000 | 0.421 ± 0.01 | 0.359 ± 0.02 | 94.63 |
800 | 0.592 ± 0.01 | 0.268 ± 0.01 | 73.99 | |
600 | 0.712 ± 0.02 | 0.199 ± 0.01 | 60.98 | |
400 | 0.884 ± 0.03 | 0.125 ± 0.02 | 45.35 | |
200 | 1.072 ± 0.05 | 0.095 ± 0.01 | 31.14 | |
100 | 1.256 ± 0.01 | 0.084 ± 0.01 | 18.04 | |
Indomethacin (200) | 0.09 ± 0.01 | 0.08 ± 0.01 | 99.3 | |